• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用阿莫沙生和长波长紫外线对血小板及血浆成分中的疟原虫和巴贝斯虫进行光化学灭活。

Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.

作者信息

Grellier Philippe, Benach Jorge, Labaied Mehdi, Charneau Sébastien, Gil Horacio, Monsalve Gloria, Alfonso Ryan, Sawyer Lynette, Lin Lily, Steiert Matthias, Dupuis Kent

机构信息

Biologie Fonctionnelle des Protozoaires, Muséum National d'Histoire Naturelle, Paris, France.

出版信息

Transfusion. 2008 Aug;48(8):1676-84. doi: 10.1111/j.1537-2995.2007.01762.x. Epub 2008 May 22.

DOI:10.1111/j.1537-2995.2007.01762.x
PMID:18503613
Abstract

BACKGROUND

Transfusion-transmitted cases of malaria and babesiosis have been well documented. Current efforts to screen out contaminated blood products result in component wastage due to the lack of specific detection methods while donor deferral does not always guarantee safe blood products. This study evaluated the efficacy of a photochemical treatment (PCT) method with amotosalen and long-wavelength ultraviolet light (UVA) to inactivate these agents in red blood cells (RBCs) contaminating platelet (PLT) and plasma components.

STUDY DESIGN AND METHODS

Plasmodium falciparum- and Babesia microti-contaminated RBCs seeded into PLT and plasma components were treated with 150 micromol per L amotosalen and 3 J per cm2 UVA. The viability of both pathogens before and after treatment was measured with infectivity assays. Treatment with 150 micromol per L amotosalen and 1 J per cm2 UVA was used to assess the robustness of the PCT system.

RESULTS

No viable B. microti was detected in PLTs or plasma after treatment with 150 mol per L amotosalen and 3 J per cm2 UVA, demonstrating a mean inactivation of greater than 5.3 log in PLTs and greater than 5.3 log in plasma. After the same treatment, viable P. falciparum was either absent or below the limit of quantification in three of four replicate experiments both in PLTs and in plasma demonstrating a mean inactivation of at least 6.0 log in PLTs and at least 6.9 log in plasma. Reducing UVA dose to 1 J per cm2 did not significantly affect the level of inactivation.

CONCLUSION

P. falciparum and B. microti were highly sensitive to inactivation by PCT. Pathogen inactivation approaches could reduce the risk of transfusion-transmitted parasitic infections and avoid unnecessary donor exclusions.

摘要

背景

输血传播疟疾和巴贝斯虫病的病例已有充分记录。由于缺乏特异性检测方法,目前筛查受污染血液制品的努力导致成分浪费,而推迟献血并不总能保证血液制品的安全。本研究评估了用氨甲环酸和长波紫外线(UVA)进行光化学处理(PCT)方法对污染血小板(PLT)和血浆成分的红细胞(RBC)中这些病原体的灭活效果。

研究设计与方法

将接种有恶性疟原虫和微小巴贝斯虫的红细胞接种到血小板和血浆成分中,用每升150微摩尔的氨甲环酸和每平方厘米3焦耳的UVA进行处理。通过感染性试验测量处理前后两种病原体的活力。用每升150微摩尔的氨甲环酸和每平方厘米1焦耳的UVA进行处理,以评估PCT系统的稳健性。

结果

用每升150摩尔的氨甲环酸和每平方厘米3焦耳的UVA处理后,在血小板或血浆中未检测到活的微小巴贝斯虫,表明血小板中的平均灭活率大于5.3对数,血浆中的平均灭活率大于5.3对数。经过相同处理后,在四个重复实验中的三个实验中,血小板和血浆中均未检测到活的恶性疟原虫或其含量低于定量限,表明血小板中的平均灭活率至少为6.0对数,血浆中的平均灭活率至少为6.9对数。将UVA剂量降低到每平方厘米1焦耳对灭活水平没有显著影响。

结论

恶性疟原虫和微小巴贝斯虫对PCT灭活高度敏感。病原体灭活方法可以降低输血传播寄生虫感染的风险,并避免不必要的献血者排除。

相似文献

1
Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.用阿莫沙生和长波长紫外线对血小板及血浆成分中的疟原虫和巴贝斯虫进行光化学灭活。
Transfusion. 2008 Aug;48(8):1676-84. doi: 10.1111/j.1537-2995.2007.01762.x. Epub 2008 May 22.
2
Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.氨甲环酸与血小板及血浆成分的相互作用:光化学处理后无新抗原形成。 (注:原文中“Amotosalen”有误,应该是“Amicar”即氨甲环酸,这里按照正确内容翻译)
Transfusion. 2005 Oct;45(10):1610-20. doi: 10.1111/j.1537-2995.2005.00554.x.
3
Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.在小鼠输血模型中,用盐酸氨甲环酸和紫外线A光对血小板浓缩物进行光化学处理可使游离和潜伏的巨细胞病毒失活。
Transfusion. 2004 Aug;44(8):1159-65. doi: 10.1111/j.1537-2995.2004.03351.x.
4
In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.利用阿莫沙啉对人血小板浓缩物和血浆中与细胞相关的人类I型和II型T细胞白血病病毒进行体外光化学灭活。
Transfusion. 2005 Jul;45(7):1151-9. doi: 10.1111/j.1537-2995.2005.04400.x.
5
The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets.盐酸氨甲环酸与紫外线A光化学处理(INTERCEPT)对混合血沉棕黄层血小板中克氏锥虫的灭活效果。
Transfusion. 2007 Mar;47(3):434-41. doi: 10.1111/j.1537-2995.2007.01133.x.
6
Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.用阿莫沙生和长波紫外线对血小板浓缩物进行光化学处理可灭活多种致病细菌。
Transfusion. 2004 Oct;44(10):1496-504. doi: 10.1111/j.1537-2995.2004.04125.x.
7
Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.评估 MIRASOL 病原体 [更正]减少技术系统对单采血小板和血浆中的微小巴贝斯虫的作用。
Transfusion. 2010 May;50(5):1019-27. doi: 10.1111/j.1537-2995.2009.02538.x. Epub 2009 Dec 18.
8
Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.使用盐酸氨甲环酸和紫外线进行光化学处理对血小板进行病原体灭活:SPRINT试验中使用的方法。
Transfusion. 2006 Apr;46(4):562-71. doi: 10.1111/j.1537-2995.2006.00761.x.
9
Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.通过用氨甲环酸和紫外线A照射处理使人类血小板浓缩物中的细小病毒B19失活。
Transfusion. 2007 Jun;47(6):1062-70. doi: 10.1111/j.1537-2995.2007.01237.x.
10
Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats.通过对新生大鼠进行为期1个月的静脉毒性研究,评估经氨甲环酸光化学病原体灭活处理制备的血小板和血浆用于新生儿输血的安全性。
Transfusion. 2009 May;49(5):985-94. doi: 10.1111/j.1537-2995.2008.02076.x. Epub 2009 Jan 21.

引用本文的文献

1
Spectroscopic view on the interaction between the psoralen derivative amotosalen and DNA.补骨脂素衍生物阿莫罗芬与DNA相互作用的光谱学研究
Photochem Photobiol Sci. 2024 Apr;23(4):693-709. doi: 10.1007/s43630-024-00545-2. Epub 2024 Mar 8.
2
Transfusion-transmitted spp.: a changing landscape of epidemiology, regulation, and risk mitigation.经输血传播的 spp.:流行病学、监管和风险缓解的变化格局。
J Clin Microbiol. 2023 Oct 24;61(10):e0126822. doi: 10.1128/jcm.01268-22. Epub 2023 Sep 26.
3
RND Pump-Mediated Efflux of Amotosalen, a Compound Used in Pathogen Inactivation Technology to Enhance Safety of Blood Transfusion Products, May Compromise Its Gram-Negative Anti-Bacterial Activity.
RND 泵介导的氨甲喋呤外排,一种用于病原体灭活技术以提高输血产品安全性的化合物,可能会损害其革兰氏阴性抗菌活性。
mSphere. 2023 Apr 20;8(2):e0067322. doi: 10.1128/msphere.00673-22. Epub 2023 Feb 28.
4
Transfusion-Transmitted Malaria and Mitigation Strategies in Nonendemic Regions.非流行地区的输血传播疟疾及缓解策略
Transfus Med Hemother. 2022 Jul 15;49(4):205-217. doi: 10.1159/000525414. eCollection 2022 Aug.
5
Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction.使用阿莫司汀和谷胱甘肽病原体减少技术对红细胞浓缩物中的恶性疟原虫进行稳健灭活。
Transfusion. 2022 May;62(5):1073-1083. doi: 10.1111/trf.16867. Epub 2022 Apr 6.
6
Pathogen Reduction for Platelets-A Review of Recent Implementation Strategies.血小板的病原体灭活——近期实施策略综述
Pathogens. 2022 Jan 24;11(2):142. doi: 10.3390/pathogens11020142.
7
Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light.使用阿莫沙林和紫外线A光对血浆和血小板进行光化学处理可使多种病毒和寄生虫失活。
Transfusion. 2020 Jun;60(6):1319-1331. doi: 10.1111/trf.15807. Epub 2020 Apr 24.
8
Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology.应用阿莫司汀和谷胱甘肽病原体减少技术在全血中灭活恶性疟原虫。
Transfusion. 2020 Apr;60(4):799-805. doi: 10.1111/trf.15734. Epub 2020 Mar 4.
9
Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting.传染病在欧盟爆发期间血液成分的病原体减少:来自欧洲疾病预防控制中心磋商会议的专家意见。
Blood Transfus. 2019 Nov;17(6):433-448. doi: 10.2450/2019.0288-19. Epub 2019 Dec 11.
10
Evaluation of bacterial inactivation in random donor platelets and single-donor apheresis platelets by the INTERCEPT blood system.采用INTERCEPT血液系统评估随机供者血小板和单采血小板中细菌的灭活情况。
Asian J Transfus Sci. 2018 Jul-Dec;12(2):146-153. doi: 10.4103/ajts.AJTS_87_17.